(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars’ ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...

HHS Secretary Robert F. Kennedy Jr. used discredited and misrepresented studies to justify canceling research into ...

Jay Bhattacharya is director of the National Institutes of Health.

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...